-
Granules Pharmaceuticals clears US FDA audit
expresspharma
July 23, 2021
The company had undergone the PAI audit by the US Food and Drug Administration (FDA) from 21st June, 2021 to 25th June, 2021.
-
PAI Partners close to acquiring vaccine vial supplier, SGD Pharma
expresspharma
June 18, 2021
As per sources, the transaction was expected to value SGD Pharma at around 10 times its core earnings, which stood at around 90 million euros ($109.15 million) last year.
-
Carbogen Amcis API Site Passes FDA PAI
contractpharma
August 08, 2019
Completes successful FDA inspection of its Neuland site in Hunzenschwil, Switzerland with no Form 483s.
-
Cytovance Completes Second FDA PAI of Oklahoma Facilities
contractpharma
June 20, 2019
Demonstrates capabilities and cGMP compliance in manufacturing commercial products.
-
Dalton Pharma Services Completes PAI Inspection
contractpharma
May 16, 2019
Paves way for Dalton to manufacture commercial API products for U.S. distribution.
-
WuXi STA receives PAI from the US FDA
biospectrumasia
May 08, 2018
This is the first time that WuXi STA's Changzhou facility has been inspected by the FDA
-
Tapemark Passes Regulatory Hurdle
contractpharma
June 08, 2017
Manufacturing facility completes successful FDA pre-approval and general GMP inspection